Cathepsin G

[1]. T Yamazaki, et al. Cathepsin G binds to human lymphocytes. J Leukoc Biol. 1997 Jan;61(1):73-9. [Content Brief]

[2]. T Hase-Yamazaki, et al. Stimulation of human lymphocytes by cathepsin G. Cell Immunol. 1995 Jan;160(1):24-32. [Content Brief]

[3]. T Yamazaki, et al. Cathepsin G enhances human natural killer cytotoxicity. Immunology. 1998 Jan;93(1):115-21. [Content Brief]

[4]. C E Alford, et al. Listericidal activity of human neutrophil cathepsin G. J Gen Microbiol. 1990 Jun;136(6):997-100. [Content Brief]

[5]. M A Selak, et al. Cathepsin G is a strong platelet agonist released by neutrophils. Biochem J. 1988 Apr 1;251(1):293-9. [Content Brief]

[6]. Jeffrey S Kavanaugh, et al. Cathepsin G Degrades Staphylococcus aureus Biofilms. J Infect Dis. 2021 Jun 4;223(11):1865-1869. [Content Brief]

[7]. Andrew J Gale, et al. Cathepsin G, a leukocyte protease, activates coagulation factor VIII. Thromb Haemost. 2008 Jan;99(1):44-51. [Content Brief]

[8]. C M Maison, et al. Proteolysis of C3 on U937 cell plasma membranes. Purification of cathepsin G. J Immunol. 1991 Aug 1;147(3):921-6. [Content Brief]

[9]. W M Shafer, et al. Molecular mechanism for the antigonococcal action of lysosomal cathepsin G. Mol Microbiol. 1990 Aug;4(8):1269-77. [Content Brief]

[10]. G R Sambrano, et al. Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem. 2000 Mar 10;275(10):6819-23. [Content Brief]

[11]. J R Biggs, et al. The human brm protein is cleaved during apoptosis: the role of cathepsin G. Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3814-9. [Content Brief]

[12]. Jing Guo, et al. Cathepsin G cleaves and activates IL-36γ and promotes the inflammation of psoriasis. Drug Des Devel Ther. 2019 Feb 8;13:581-588. [Content Brief]

[13]. N Bangalore, et al. Identification of the primary antimicrobial domains in human neutrophil cathepsin G. J Biol Chem. 1990 Aug 15;265(23):13584-8. [Content Brief]

[14]. Shan Huang, et al. Cathepsin g Degrades Both Glycosylated and Unglycosylated Regions of Lubricin, a Synovial Mucin. Sci Rep. 2020 Mar 6;10(1):4215. [Content Brief]

[15]. Emma Lefrançais, et al. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1673-8. [Content Brief]

[16]. M Molino, et al. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. J Biol Chem. 1995 May 12;270(19):11168-75. [Content Brief]

[17]. Josh C Woloszynek, et al. Cathepsin G-regulated release of formyl peptide receptor agonists modulate neutrophil effector functions. J Biol Chem. 2012 Oct 5;287(41):34101-9. [Content Brief]

[18]. L E Avril, et al. Identification of the U-937 membrane-associated proteinase interacting with the V3 loop of HIV-1 gp120 as cathepsin G. FEBS Lett. 1994 May 23;345(1):81-6. [Content Brief]

[19]. Hye-Kyoung Jun, et al. Caspase-4 activation by a bacterial surface protein is mediated by cathepsin G in human gingival fibroblasts. Cell Death Differ. 2018 Feb;25(2):380-391. [Content Brief]

[20]. Jean K Lim, et al. N-terminal proteolytic processing by cathepsin G converts RANTES/CCL5 and related analogs into a truncated 4-68 variant. J Leukoc Biol. 2006 Dec;80(6):1395-404. [Content Brief]

[21]. K R Wasiluk, et al. Comparison of granule proteins from human polymorphonuclear leukocytes which are bactericidal toward Pseudomonas aeruginosa. Infect Immun. 1991 Nov;59(11):4193-200. [Content Brief]

[22]. Ronghua Sun, et al. Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor. J Immunol. 2004 Jul 1;173(1):428-36. [Content Brief]

[23]. Michael Thorpe, et al. Extended cleavage specificity of human neutrophil cathepsin G: A low activity protease with dual chymase and tryptase-type specificities. PLoS One. 2018 Apr 13;13(4):e0195077. [Content Brief]

[24]. Timo Burster, et al. Cathepsin G, and not the asparagine-specific endoprotease, controls the processing of myelin basic protein in lysosomes from human B lymphocytes. J Immunol. 2004 May 1;172(9):5495-503. [Content Brief]

[25]. J Plescia, et al. Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation. Biochem J. 1996 Nov 1;319 ( Pt 3)(Pt 3):873-9. [Content Brief]

[26]. Agnès Mambole, et al. The cleavage of neutrophil leukosialin (CD43) by cathepsin G releases its extracellular domain and triggers its intramembrane proteolysis by presenilin/gamma-secretase. J Biol Chem. 2008 Aug 29;283(35):23627-35. [Content Brief]

[27]. Carlos A Rivera-Marrero, et al. The down-regulation of cathepsin G in THP-1 monocytes after infection with Mycobacterium tuberculosis is associated with increased intracellular survival of bacilli. Infect Immun. 2004 Oct;72(10):5712-21. [Content Brief]